Affibody
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metast Metastatic Breast Cancer, HER2 + Breast Cancer | Phase 1 | 2025-10-06 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 Psoriasis | Phase 1 | 2019-11-13 |
| Completed | A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2018-03-07 |
| Terminated | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-039 Healthy Volunteers | Phase 1 | 2018-02-26 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 Psoriasis, Healthy Subjects | Phase 1 | 2016-02-01 |